Table 2. AMTSL with and without WHO SCC utilization.
Study | AMTSL without WHO SCC (Number / total and %) | AMTSL with WHO SCC (Number/ total and %) | P-value |
---|---|---|---|
1. Kumar et al. [7] | 58/240(24%) | 211/240(88%) | <0.001 |
2. Nababan et al. [11] | 134/153(88%) | 156/157(99%) | <0.001 |
3. Semrau et al. [21] | 154/1041(14.8%) | 549/1019(53.9%) | <0.001 |
4. Spector et al. [3] | 33/338(8.4%) | 402/583(68.9%) | <0.001 |
5. Tuyishim et al. [10] | 76/92(77.6%) | 84/98(84.8%) | 0.206 |
6. Varaganti et al. [12] | 600/635(94.5%) | 601/620(96.9%) | 0.032 |